Russian Venture Company sets up medical technology fund with R-Pharm

 Russian Venture Company (RVC), the Russian government’s fund of funds, has joined forces  with the R-Pharm pharmaceutical company to launch a fund that will focus exclusively on  investing in medical technology. RusBio Ventures will have the capacity to invest up to $39m in medical technology and in IT companies working in the biomedicine with at least 50% of  investment being directed to Russian startups. The fund is initially looking to set up a portfolio of between eight and ten companies. Rusbase